Schedule 13D ownership disclosure

SPECTRUM PHARMACEUTICALS INC

Security class unavailable · CUSIP: 84763A108

Event date: 2016-07-26

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
8,817,649
Percent of class
10.2300%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001193918-16-000002
Form type
SC 13D/A
Filer
SHROTRIYA RAJESH C MD
CIK
CIK 1193918
Filed
Aug 17, 2016
Reporting period
Jul 26, 2016
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub